Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy

Li,Li; Fukumoto,Manabu; Liu,Duo

doi:10.3892/ol.2013.1627

Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy

Authors:
- Li Li
- Manabu Fukumoto
- Duo Liu
View Affiliations

Affiliations: Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical College, Zhanjiang, Guangdong, P.R. China, Department of Pathology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan
Published online on: October 15, 2013 https://doi.org/10.3892/ol.2013.1627
Pages: 1611-1615

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

p53 status is a key biomarker for a variety of cancer types. However, it remains controversial whether p53 is an effective biomarker in oral squamous cell carcinoma (OSCC), particularly with regard to its prognostic value for OSCC patients with combinational treatment. The aim of the current study was to evaluate the prognostic potential of p53 immunoexpression in samples from OSCC patients treated with surgery only or surgery and neoadjuvant chemotherapy. p53 expression was assessed immunohistochemically in biopsy tissues from 44 OSCC patients with a mean follow‑up of 35.6 months. Correlations between p53 status, tumor size (T‑classification), lymph node status (N‑classification) and clinical outcome were analyzed. It was observed that p53‑positive and N0 cases correlated with higher 5‑year survival rates in cases treated with surgery alone (P=0.017 and P=0.03, respectively), while in cases with neoadjuvant chemotherapy, p53 status and lymph node status did not exhibit prognostic significance. Tumor size showed no prognostic value in cases receiving surgery alone or in those with neoadjuvant chemotherapy. The present results demonstrated for the first time that p53 immunohistochemical expression correlates with a good prognosis in OSCC patients receiving surgery alone. In conclusion, p53 immunohistochemical expression and lymph node status may serve as prognostic markers for the survival of OSCC patients receiving surgery only, but not for patients undergoing surgery and neoadjuvant chemotherapy treatment.

View Figures

View References

1	Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
2	Khuri FR, Lee JJ, Lippman SM, et al: Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 98:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
3	Gasparotto D and Maestro R: Molecular approaches to the staging of head and neck carcinomas (review). Int J Oncol. 31:175–180. 2007.PubMed/NCBI
4	Shibata M, Kodani I, Osaki M, et al: Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol. 41:304–312. 2005. View Article : Google Scholar : PubMed/NCBI
5	Kodani I, Shomori K, Osaki M, Kuratate I, Ryoke K and Ito H: Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa. Pathobiology. 69:150–158. 2001. View Article : Google Scholar : PubMed/NCBI
6	Lumerman H, Freedman P and Kerpel S: Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 79:321–329. 1995. View Article : Google Scholar : PubMed/NCBI
7	Silverman S Jr, Gorsky M and Lozada F: Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 53:563–568. 1984. View Article : Google Scholar : PubMed/NCBI
8	Banoczy J and Csiba A: Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases. Oral Surg Oral Med Oral Pathol. 42:766–774. 1976. View Article : Google Scholar : PubMed/NCBI
9	Kalavrezos N and Bhandari R: Current trends and future perspectives in the surgical management of oral cancer. Oral Oncol. 46:429–432. 2010. View Article : Google Scholar : PubMed/NCBI
10	Guimaraes DP and Hainaut P: TP53: a key gene in human cancer. Biochimie. 84:83–93. 2002. View Article : Google Scholar : PubMed/NCBI
11	Oren M: Decision making by p53: life, death and cancer. Cell Death Differ. 10:431–442. 2003. View Article : Google Scholar : PubMed/NCBI
12	Gasco M and Crook T: The p53 network in head and neck cancer. Oral Oncol. 39:222–231. 2003. View Article : Google Scholar : PubMed/NCBI
13	Brosh R and Rotter V: When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer. 9:701–713. 2009.PubMed/NCBI
14	Soussi T and Béroud C: Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer. 1:233–240. 2001. View Article : Google Scholar : PubMed/NCBI
15	Perisanidis C, Perisanidis B, Wrba F, et al: Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med. 41:40–46. 2012. View Article : Google Scholar : PubMed/NCBI
16	Coutinho-Camillo CM, Lourenco SV, Nishimoto IN, Kowalski LP and Soares FA: Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray. Hum Pathol. 41:1079–1086. 2010. View Article : Google Scholar : PubMed/NCBI
17	Kato K, Kawashiri S, Tanaka A, et al: Predictive value of measuring p53 labeling index at the invasive front of oral squamous cell carcinomas. Pathol Oncol Res. 14:57–61. 2008. View Article : Google Scholar : PubMed/NCBI
18	Oliveira LR, Ribeiro-Silva A, Costa JP, Simões AL, Matteo MA and Zucoloto S: Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 106:685–695. 2008. View Article : Google Scholar : PubMed/NCBI
19	International Union Against Cancer. TNM Classification of Malignant Tumours. Wiley-Liss; New York, NY: 2000
20	Howaldt HP, Kainz M, Euler B and Vorast H: Proposal for modification of the TNM staging classification for cancer of the oral cavity. DOSAK J Craniomaxillofac Surg. 27:275–288. 1999. View Article : Google Scholar : PubMed/NCBI
21	Kreppel M, Drebber U, Eich HT, et al: Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy. Strahlenther Onkol. 187:555–560. 2011. View Article : Google Scholar : PubMed/NCBI
22	Kim SY, Nam SY, Choi SH, Cho KJ and Roh JL: Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma. Ann Surg Oncol. 18:2310–2317. 2011. View Article : Google Scholar : PubMed/NCBI
23	Pillai KR, Sujathan K, Madhavan J and Abraham EK: Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis. In Vivo. 19:807–812. 2005.PubMed/NCBI
24	Iype EM, Pandey M, Mathew A, Thomas G and Nair MK: Squamous cell cancer of the buccal mucosa in young adults. Br J Oral Maxillofac Surg. 42:185–189. 2004. View Article : Google Scholar : PubMed/NCBI
25	Girod SC, Krueger G and Pape HD: p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int J Oral Maxillofac Surg. 22:285–288. 1993. View Article : Google Scholar : PubMed/NCBI
26	Olivier M, Hainaut P and Borresen-Dale A: Prognostic and predictive value of TP53 mutations in human cancer. 25 Years of p53 Research. Hainaut P and Wiman K: Springer; Dordrecht, the Netherlands: pp. 321–338. 2005, View Article : Google Scholar
27	Jäättelä M: Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene. 23:2746–2756. 2004.PubMed/NCBI
28	Igney FH and Krammer PH: Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2:277–288. 2002. View Article : Google Scholar : PubMed/NCBI
29	Zheng H, Takahashi H, Murai Y, et al: Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol. 60:273–277. 2007. View Article : Google Scholar
30	Jackson JG, Pant V, Li Q, et al: p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell. 21:793–806. 2012. View Article : Google Scholar : PubMed/NCBI